Microbiota–innate immune crosstalk drives atherosclerosis: mechanisms, disease progression, and emerging therapeutic strategies
The microbiota–innate immune axis provides a novel conceptual framework for understanding atherosclerosis pathogenesis and represents a promising target for future disease prevention, risk stratification, and precision therapeutics.